share_log

复星医药关于控股子公司获美国FDA药品临床试验批准的公告

Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for clinical trials of drugs by the US FDA

Sensex a share ·  May 7

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.